There was a reduction in volume of involvement, cardiac pyrophosphate activity, native T1, and extracellular volume during a median of 369 days between scans in patients with ATTR-CM being treated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback